The high density of defects in MAPbI3 perovskite films
brings about severe carrier nonradiative recombination loss, which
lowers the performance of MAPbI3-based perovskite solar
cells (PSCs). Here, methylamine cyanate (MAOCN) molecules were introduced
into MAPbI3 solutions to manipulate the crystallizatsion
of the MAPbI3 films. MAOCN molecules can slow down the
volatilization rate of the solvent and delay the crystallization process
of the MAPbI3 film. The crystal quality of the MAPbI3 films is effectively optimized without an additive residue.
Perovskite films treated by MAOCN have lower defect density and longer
carrier lifetime, which lowers the carrier recombination loss. Meanwhile,
the MAPbI3 film based on MAOCN has a more hydrophobic surface.
The final MAPbI3-based device efficiency reached 21.28%
(V
OC = 1.126 V, J
SC = 23.29 mA/cm2, and FF = 81.13). After 30 days
of storage under atmospheric conditions, the efficiency of unencapsulated
MAOCN-based PSCs only dropped by about 5%.